1. Home
  2. CTXR vs FEBO Comparison

CTXR vs FEBO Comparison

Compare CTXR & FEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTXR
  • FEBO
  • Stock Information
  • Founded
  • CTXR 2007
  • FEBO 1993
  • Country
  • CTXR United States
  • FEBO Hong Kong
  • Employees
  • CTXR N/A
  • FEBO N/A
  • Industry
  • CTXR Biotechnology: Pharmaceutical Preparations
  • FEBO
  • Sector
  • CTXR Health Care
  • FEBO
  • Exchange
  • CTXR Nasdaq
  • FEBO Nasdaq
  • Market Cap
  • CTXR 14.6M
  • FEBO 12.7M
  • IPO Year
  • CTXR N/A
  • FEBO 2023
  • Fundamental
  • Price
  • CTXR $0.86
  • FEBO $1.20
  • Analyst Decision
  • CTXR Strong Buy
  • FEBO
  • Analyst Count
  • CTXR 3
  • FEBO 0
  • Target Price
  • CTXR $54.50
  • FEBO N/A
  • AVG Volume (30 Days)
  • CTXR 153.2K
  • FEBO 7.9K
  • Earning Date
  • CTXR 05-14-2025
  • FEBO 06-17-2025
  • Dividend Yield
  • CTXR N/A
  • FEBO N/A
  • EPS Growth
  • CTXR N/A
  • FEBO N/A
  • EPS
  • CTXR N/A
  • FEBO N/A
  • Revenue
  • CTXR N/A
  • FEBO $17,110,653.00
  • Revenue This Year
  • CTXR N/A
  • FEBO N/A
  • Revenue Next Year
  • CTXR N/A
  • FEBO N/A
  • P/E Ratio
  • CTXR N/A
  • FEBO N/A
  • Revenue Growth
  • CTXR N/A
  • FEBO 11.58
  • 52 Week Low
  • CTXR $0.65
  • FEBO $0.93
  • 52 Week High
  • CTXR $26.25
  • FEBO $17.68
  • Technical
  • Relative Strength Index (RSI)
  • CTXR 51.82
  • FEBO 49.74
  • Support Level
  • CTXR $0.80
  • FEBO $1.11
  • Resistance Level
  • CTXR $0.92
  • FEBO $1.40
  • Average True Range (ATR)
  • CTXR 0.08
  • FEBO 0.13
  • MACD
  • CTXR 0.03
  • FEBO -0.01
  • Stochastic Oscillator
  • CTXR 62.41
  • FEBO 39.76

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

About FEBO Fenbo Holdings Limited

Fenbo Holdings Ltd is a company engaged in producing premium personal care c principally electrical hair styling products such as straighteners, curlers, trimmers, etc., and toy products to overseas markets. It manufactures and sells products such as Straightener, Mini Straightener, and Curling Iron.

Share on Social Networks: